SAMUELSON JAMES F 4
4 · CANNAPHARMARX, INC. · Filed Feb 3, 2020
Insider Transaction Report
Form 4
SAMUELSON JAMES F
Director
Transactions
- Sale
Series A Convertible Preferred Stock
2018-04-23$1.00/sh−4,000$4,000→ 16,000 totalExercise: $0.00From: 2018-04-20→ Common Stoc (5,000,000 underlying) - Sale
Series A Convertible Preferred Stock
2018-04-23$1.00/sh−1,200$1,200→ 14,800 totalExercise: $0.00From: 2018-04-20→ Common Stoc (1,500,000 underlying)
Footnotes (3)
- [F1]Each share of the Series A Convertible Preferred Stock are convertible into 1,250 shares of Common Stock of the Issuer.
- [F2]The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time.
- [F3]These shares were sold to the Company's Vice-President of Strategic Development and its legal counsel, respectively.